Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Oncotarget|July 8, 2016
uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapyMiguel Angel Pavón, Irene Arroyo-Solera, Maria Virtudes Céspedes, et al.Current Opinion in Pharmacology|January 28, 2019
Protein-driven nanomedicines in oncotherapyIsolda Casanova, Ugutz Unzueta, Irene Arroyo-Solera, et al.Head & Neck|January 18, 2019
The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypesMiguel Angel Pavón, Irene Arroyo-Solera, Xavier León, et al.Haematologica|June 29, 2019
A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse modelsAïda Falgàs, Victor Pallarès, Ugutz Unzueta, et al.Head & Neck|December 15, 2018
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinomaIrene Arroyo-Solera, Miguel Ángel Pavón, Xavier León, et al.Journal of Experimental & Clinical Cancer Research : CR|February 5, 2022
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinomaElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.Pharmaceutics|April 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse ModelElisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, et al.Acta Pharmaceutica Sinica. B|June 1, 2022
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4<sup>+</sup> head and neck squamous cell carcinoma tumorsElisa Rioja-Blanco, Irene Arroyo-Solera, Patricia Álamo, et al.Cancer Medicine|January 10, 2014
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinomaMarta Téllez-Gabriel, Irene Arroyo-Solera, Xavier León, et al.Head & Neck|October 31, 2015
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinomaMiguel Angel Pavón, Matilde Parreño, Marta Téllez-Gabriel, et al.Pageof 2